These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20380589)

  • 21. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases.
    Akdis M; Blaser K; Akdis CA
    J Allergy Clin Immunol; 2005 Nov; 116(5):961-8; quiz 969. PubMed ID: 16275361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells.
    Suzuki M; Zheng X; Zhang X; Zhang ZX; Ichim TE; Sun H; Nakamura Y; Inagaki A; Beduhn M; Shunnar A; Garcia B; Min WP
    J Allergy Clin Immunol; 2010 Mar; 125(3):737-43, 743.e1-743.e6. PubMed ID: 20226305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological mechanisms in specific immunotherapy.
    Schmidt-Weber CB; Blaser K
    Springer Semin Immunopathol; 2004 Feb; 25(3-4):377-90. PubMed ID: 15007636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.
    Jutel M; Akdis M; Budak F; Aebischer-Casaulta C; Wrzyszcz M; Blaser K; Akdis CA
    Eur J Immunol; 2003 May; 33(5):1205-14. PubMed ID: 12731045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The regulation of allergy and asthma.
    Umetsu DT; DeKruyff RH
    Immunol Rev; 2006 Aug; 212():238-55. PubMed ID: 16903918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosensor-based characterization of serum antibodies during development of an anti-IgE immunotherapeutic against allergy and asthma.
    Pol E; Karlsson R; Roos H; Jansson A; Xu B; Larsson A; Jarhede T; Franklin G; Fuentes A; Persson S
    J Mol Recognit; 2007; 20(1):22-31. PubMed ID: 17036306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
    Taube C; Buhl R
    Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy: an option in the management of occupational asthma?
    Sastre J; Quirce S
    Curr Opin Allergy Clin Immunol; 2006 Apr; 6(2):96-100. PubMed ID: 16520672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
    Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
    Jacobsen L; Valovirta E
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
    Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
    Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Treg in immune regulation of allergic diseases.
    Palomares O; Yaman G; Azkur AK; Akkoc T; Akdis M; Akdis CA
    Eur J Immunol; 2010 May; 40(5):1232-40. PubMed ID: 20148422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells as potential immunotherapy in allergy.
    Wing K; Sakaguchi S
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):482-8. PubMed ID: 17088656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-specific immunotherapy for the treatment of allergic diseases].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2000 May; 8(47):309-15. PubMed ID: 10944949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.
    Machiels JJ; Somville MA; Lebrun PM; Lebecque SJ; Jacquemin MG; Saint-Remy JM
    J Clin Invest; 1990 Apr; 85(4):1024-35. PubMed ID: 2318962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.